CytoSorbents (CSTO) Bullish View Reiterated at Maxim Group on Commercial Launch of CytoSorb for Cardiac Surgery

October 4, 2016 12:16 PM EDT
Get Alerts CTSO Hot Sheet
Price: $5.95 --0%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 10 | New: 7
Trade CTSO Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Maxim Group analyst Jason Kolbert reiterated a Buy rating and $8 price target on CytoSorbents (NASDAQ: CTSO) after the company announced its strategic partner Terumo Cardiovascular Group has initiated international commercialization of CytoSorb for use during complex cardiac surgery at the European Association for Cardio-Thoracic Surgery (EACTS) conference in Barcelona, Spain (October 1-5, 2016).

Kolbert highlighted:

  • Terumo will distribute the CytoSorb cardiopulmonary bypass (CPB) procedure pack for cardiac surgery in France, Sweden, Denmark, Norway, Finland, and Iceland. Following the EACTS conference, Terumo plans to host a two-day scientific program in Nice, France with cardiac surgery perfusionists to discuss innovative perfusion strategies and the application of CytoSorb.
  • Recall that CytoSorbents announced a multi-country strategic partnership with Terumo Cardiovascular Group, a subsidiary of Japan-based Terumo Corporation, in September 2016. Under the terms of the agreement, Terumo will have exclusive rights to distribute the CytoSorb cardiopulmonary bypass (CPB) procedure pack for intraoperative use during cardiac surgery in France, Sweden, Denmark, Norway, Finland and Iceland.
  • Conclusion. CytoSorbents continues to expand its commercial efforts in indications beyond sepsis. We look forward to data from the U.S. REFRESH study coming this quarter, followed by a pivotal REFRESH II study in 1Q17.

For an analyst ratings summary and ratings history on CytoSorbents click here. For more ratings news on CytoSorbents click here.

Shares of CytoSorbents closed at $6.73 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments

Related Entities

Maxim Group

Add Your Comment